Abstract:Mitochondria are essential to cellular function as they generate the majority of cellular ATP, mediated through oxidative phosphorylation, which couples proton pumping of the electron transport chain (ETC) to ATP production. The ETC generates an electrochemical gradient, known as the proton motive force, consisting of the mitochondrial membrane potential (ΔΨm, the major component in mammals) and ΔpH across the inner mitochondrial membrane. Both ATP production and reactive oxygen species (ROS) are linked to ΔΨm, and it has been shown that an imbalance in ΔΨm beyond the physiological optimal intermediate range results in excessive ROS production. The reaction of cytochrome c oxidase (COX) of the ETC with its small electron donor cytochrome c (Cytc) is the proposed rate-limiting step in mammals under physiological conditions. The rate at which this redox reaction occurs controls ΔΨm and thus ATP and ROS production. Multiple mechanisms are in place that regulate this reaction to meet the cell's energy demand and respond to acute stress. COX and Cytc have been shown to be regulated by all three main mechanisms, which we discuss in detail: allosteric regulation, tissue-specific isoforms, and post-translational modifications for which we provide a comprehensive catalog and discussion of their functional role with 55 and 50 identified phosphorylation and acetylation sites on COX, respectively. Disruption of these regulatory mechanisms has been found in several common human diseases, including stroke and myocardial infarction, inflammation including sepsis, and diabetes, where changes in COX or Cytc phosphorylation lead to mitochondrial dysfunction contributing to disease pathophysiology. Identification and subsequent targeting of the underlying signaling pathways holds clear promise for future interventions to improve human health. An example intervention is the recently discovered noninvasive COX-inhibitory infrared light therapy that holds promise to transform the current standard of clinical care in disease conditions where COX regulation has gone awry.

The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology

Metabolic Targets of Coenzyme Q10 in Mitochondria

Understanding Coenzyme Q

Coenzyme Q at the Hinge of Health and Metabolic Diseases

Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation

Disorders of Human Coenzyme Q10 Metabolism: An Overview

Mitochondrial complex III Rieske Fe-S protein processing and assembly

An ETFDH-driven metabolon supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis

Interaction with Artificial Electron Acceptors, Inhibitors, and Potential Medicines

The Roles of Coenzyme Q in Disease: Direct and Indirect Involvement in Cellular Functions

Optimizing metabolism is a complex issue

Mitochondrial microproteins link metabolic cues to respiratory chain biogenesis

Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme

Biosynthesis, Deficiency, and Supplementation of Coenzyme Q

Assembly of mitochondrial succinate dehydrogenase in human health and disease

Regulation of mitochondrial oxidative phosphorylation through tight control of cytochrome c oxidase in health and disease - Implications for ischemia/reperfusion injury, inflammatory diseases, diabetes, and cancer

The coupling mechanism of mammalian mitochondrial complex I

Electrochemical detection of quinone reduced by Complex I Complex II and Complex III in full mitochondrial membranes

The assembly, regulation and function of the mitochondrial respiratory chain

Mitochondrial cytochrome c oxidase deficiency.